Carroll Financial Associates’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-785
Closed -$35K 1843
2021
Q1
$35K Buy
+785
New +$32.9K ﹤0.01% 853
2018
Q1
Sell
-9
Closed -$453 1338
2017
Q4
$0 Hold
9
﹤0.01% 1301
2017
Q3
$0 Hold
9
﹤0.01% 1261
2017
Q2
$0 Sell
9
-8
-47% -$336 ﹤0.01% 1242
2017
Q1
$0 Hold
17
﹤0.01% 1234
2016
Q4
$0 Hold
17
﹤0.01% 1218
2016
Q3
$0 Sell
17
-142
-89% -$4.46K ﹤0.01% 1216
2016
Q2
$4K Buy
159
+14
+10% +$425 ﹤0.01% 980
2016
Q1
$4K Hold
145
﹤0.01% 953
2015
Q4
$4K Hold
145
﹤0.01% 915
2015
Q3
$4K Hold
145
﹤0.01% 890
2015
Q2
$4K Hold
145
﹤0.01% 902
2015
Q1
$4K Hold
145
﹤0.01% 664
2014
Q4
$4K Hold
145
﹤0.01% 611
2014
Q3
$3K Hold
145
﹤0.01% 716
2014
Q2
$4K Sell
145
-1
-0.7% -$23 ﹤0.01% 755
2014
Q1
$3K Buy
146
+143
+4,767% +$3.48K ﹤0.01% 731
2013
Q4
$0 Sell
3
-143
-98% -$3.37K ﹤0.01% 889
2013
Q3
$3K Hold
146
﹤0.01% 662
2013
Q2
$2K Buy
+146
New +$2.77K ﹤0.01% 551

Other funds holding SNV

Carroll Financial Associates's SNV Position: Q2 2021 in Review

Carroll Financial Associates sold out of Synovus (SNV) in Q2 2021, closing a stake of 785 shares — an estimated $35K sold.

Carroll Financial Associates first reported a position in SNV in Q2 2013 and held it in 20 quarters. The position peaked at $35K in Q1 2021. 378 funds tracked by Wall St. Rank hold SNV as of Q2 2021.

  • Carroll Financial Associates reported no remaining Synovus position as of Q2 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 785 Synovus shares in Q2 2021, an estimated $35K.
  • Carroll Financial Associates first reported a position in Synovus in Q2 2013 and held it in 20 quarters.
  • Carroll Financial Associates's Synovus position peaked at $35K in Q1 2021.
  • 378 funds tracked by Wall St. Rank held Synovus as of Q2 2021.

Based on Carroll Financial Associates's 13F filing for Q2 2021, filed 13 Jul 2021.